Arrayjet Ltd

Stobo House
EH25 9RE
United Kingdom

0131 440 5220


Arrayjet provide instruments and services to pharma, diagnostic and lifescience industries. Our products use inkjet technology for precision picolitre liquid handling. Arrayjet focus on printing biological samples to create tools for genomic and proteomic screening, patient stratification and clinical diagnosis.

The proprietary printing technology is fully automated and delivers benefits of ease of use, precision, reproducibility, efficiency of manufacture, and total process-control.

Arrayjet's patented technology simultaneously aspirates and prints multiple samples on-the-fly. This is a proven platform and its non-contact bioprinting is ideal for microarray and 96 well microplate manufacture; as well as bioprinting onto biosensors, biochips, MEMS devices, microfluidic devices, membrane sheets or nanowell applications. Most substrates are compatible with the technology.

Arrayjet instruments offer the largest manufacturing batch size of up to 1000 slides. The instrument is modular and scalable, enabling customers to increase capacity as their requirements grow. It combines the fastest and most reliable instrumentation on the market with the versatility to print any biological sample type onto any solid substrate.


EM/Accessories Labelling

Upcoming Events

Managing Cultural Differences in the Workplace

The Holiday Inn - Kensington Forum, 97 Cromwell Road, London SW7 4DN
21 January 2019

British Society for Haematology Paediatric Symposium

Royal College of Paediatrics and Child Health, 5-11 Theobalds Road, London WC1X 8SH
14 February 2019

Challenges in the clinical biochemistry laboratory and beyond

The Royal College of Pathologists
28 February 2019

British Society for Haematology 59th Annual Scientific Meeting

SEC Glasgow
1-3 April 2019

Focus 2019

SEC Glasgow
1-3 May 2019

Latest Issue

Pathology In Practice

Pathology In Practice

Dec 2018

Molecular diagnostics and LAMP technology

Register now to apply for regular copies of Pathology In Practice and free access to premium content, as well as our regular newsletters.